Literature DB >> 2350098

Pulmonary accumulation of amiodarone and N-desethylamiodarone. Relationship to the development of pulmonary toxicity.

B D Wilson1, M L Lippmann.   

Abstract

To investigate the relationship between the amount of amiodarone and the major metabolite N-desethylamiodarone found in the lung with the development of toxicity, Fischer 344 and Wistar rats were given 175 mg/kg/day of drug by gavage. After 1, 3, 6, and 12 wk of drug feeding, both stains were examined for histologic evidence of pulmonary inflammation and for changes in lavage cell counts and differentials. The amounts of amiodarone and N-desethylamiodarone in the lungs were determined using high performance liquid chromatography. We found that in drug-fed Wistar rats the lavage differentials were unchanged, lavage cell counts were decreased compared with those in control rats, and the lungs appeared normal except for some foamy macrophages. Wistar rats also had low levels of amiodarone and metabolite in both lung tissue and cells. In contrast, Fischer rats had an increase in lavage lymphocytes, neutrophils, and macrophages compared with that in control rats and abnormal lung histologies. Also, there was much more drug and metabolite in the lungs than the amounts found in Wistar rats. Because Fischer rats had more metabolite than amiodarone in the lung and the reverse was true in Wistar rats, the in vitro cytotoxicity of amiodarone and N-desethylamiodarone were compared. We found that N-desethylamiodarone was significantly more cytotoxic than amiodarone to both fibroblasts and endothelial cells. We conclude that there is a relationship between the amounts of drug and metabolite in the lung and the development of pulmonary inflammation, and that N-desethylamiodarone may be more cytotoxic than amiodarone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350098     DOI: 10.1164/ajrccm/141.6.1553

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  4 in total

1.  Susceptibility to amiodarone-induced pulmonary toxicity: relationship to the uptake of amiodarone by isolated lung cells.

Authors:  B D Wilson; M L Lippmann
Journal:  Lung       Date:  1996       Impact factor: 2.584

Review 2.  Low dose amiodarone pulmonary toxicity in a patient with a history of pneumonectomy.

Authors:  H van der Zeyden; D Zandstra; M van Hengstum
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

3.  Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathway.

Authors:  B D Wilson; C E Clarkson; M L Lippmann
Journal:  Lung       Date:  1993       Impact factor: 2.584

4.  Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary Phospholipidosis.

Authors:  Aateka Patel; Ewelina Hoffman; Doug Ball; Jan Klapwijk; Rory T Steven; Alex Dexter; Josephine Bunch; Daniel Baker; Darragh Murnane; Victoria Hutter; Clive Page; Lea Ann Dailey; Ben Forbes
Journal:  Pharmaceutics       Date:  2019-07-17       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.